Tzu-Hsuan Huang, Ph.D. - Publications
Affiliations: | 2006 | University of California, Los Angeles, Los Angeles, CA |
Area:
ImmunologyYear | Citation | Score | |||
---|---|---|---|---|---|
2019 | Guo J, Xiao Y, Iyer R, Lu X, Lake M, Ladror U, Harlan J, Samanta T, Tomlinson M, Bukofzer G, Donawho C, Shoemaker A, Huang TH. Empowering therapeutic antibodies with IFN-α for cancer immunotherapy. Plos One. 14: e0219829. PMID 31393905 DOI: 10.1371/journal.pone.0219829 | 0.38 | |||
2008 | Cheng LS, Hwang S, Huang TH, Sheu TC, Sun R, Morrison SL, Cheng G, Shahangian A. Antibody-fused interferons as an effective approach to enhance target specificity and antiviral efficacy of type I interferons. Cell Research. 18: 1230-2. PMID 19002159 DOI: 10.1038/Cr.2008.304 | 0.534 | |||
2007 | Huang TH, Chintalacharuvu KR, Morrison SL. Targeting IFN-alpha to B cell lymphoma by a tumor-specific antibody elicits potent antitumor activities. Journal of Immunology (Baltimore, Md. : 1950). 179: 6881-8. PMID 17982079 DOI: 10.4049/Jimmunol.179.10.6881 | 0.58 | |||
2006 | Huang TH, Morrison SL. A trimeric anti-HER2/neu ScFv and tumor necrosis factor-alpha fusion protein induces HER2/neu signaling and facilitates repair of injured epithelia. The Journal of Pharmacology and Experimental Therapeutics. 316: 983-91. PMID 16291729 DOI: 10.1124/Jpet.105.095513 | 0.568 | |||
2004 | Dela Cruz JS, Huang TH, Penichet ML, Morrison SL. Antibody-cytokine fusion proteins: innovative weapons in the war against cancer. Clinical and Experimental Medicine. 4: 57-64. PMID 15672942 DOI: 10.1007/S10238-004-0039-Y | 0.437 | |||
Show low-probability matches. |